The Oncosearch | Oncotarget

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients Research Paper

Hung-Chih Hsu, Tan Kien Thiam, Yen-Jung Lu, Chien Yuh Yeh, Wen-Sy Tsai, Jeng Fu You, Hsin Yuan Hung, Chi-Neu Tsai, An Hsu, Hua-Chien Chen, Shu-Jen Chen, Tsai-Sheng Yang

Published Mar 12, 2016 · Vol. 7, No. 16 · pp. 22257-22270

Suppression of B-Raf(V600E) cancers by MAPK hyper-activation Research Paper

Rawan Atiq, Rachel Hertz, Sophia Eldad, Elia Smeir, Jacob Bar-Tana

Published Mar 4, 2016 · Vol. 7, No. 14 · pp. 18694-18704

High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor Research Paper

Le Zhang, Zhaoying Yang, Letizia Granieri, Adrian Pasculescu, Alessandro Datti, Sylvia L. Asa, Zheli Xu, Shereen Ezzat

Published Mar 3, 2016 · Vol. 7, No. 15 · pp. 19948-19959

Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer Research Paper

Eran Brauner, Viswanath Gunda, Pierre Vanden Borre, David Zurakowski, Yon Seon Kim, Kate Virginia Dennett, Salma Amin, Gordon James Freeman, Sareh Parangi

Published Mar 2, 2016 · Vol. 7, No. 13 · pp. 17194-17211

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients Research Paper

Langping Jin, Endong Chen, Siyang Dong, Yefeng Cai, Xiangjian Zhang, Yili Zhou, Ruichao Zeng, Fan Yang, Chuanmeng Pan, Yehuan Liu, Weili Wu, Mingzhao Xing, Xiaohua Zhang, Ouchen Wang

Published Mar 1, 2016 · Vol. 7, No. 14 · pp. 18346-18355

Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy Research Paper

MylÃ¨ne Sebagh, Marc-Antoine Allard, Nelly Bosselut, Myriam Dao, Eric Vibert, MaÃ¯tÃ© Lewin, Antoinette Lemoine, Daniel Cherqui, RenÃ© Adam, Antonio Sa Cunha

Published Mar 1, 2016 · Vol. 7, No. 16 · pp. 21591-21600

Mitochondrial oxidative phosphorylation controls cancer cellâ€™s life and death decisions upon exposure to MAPK inhibitors Research Paper

Paola Corazao-Rozas, Pierre Guerreschi, Fanny AndrÃ©, Pierre-Elliott Gabert, Steve Lancel, Salim Dekiouk, Delphine Fontaine, Meryem Tardivel, Ariel Savina, Bruno Quesnel, Laurent Mortier, Philippe Marchetti, JÃ©rome Kluza

Published Feb 29, 2016 · Vol. 7, No. 26 · pp. 39473-39485

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors Research Paper

Kotryna Seip, Karianne G. Fleten, Anna Barkovskaya, Vigdis Nygaard, Mads H. Haugen, Birgit Ã˜. EngesÃ¦ter, Gunhild M. MÃ¦landsmo, Lina Prasmickaite

Published Feb 24, 2016 · Vol. 7, No. 15 · pp. 19997-20015

Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression Research Paper

Johanna Eriksson, Vadim Le Joncour, Pirjo Nummela, Tiina Jahkola, Susanna Virolainen, Pirjo Laakkonen, Olli Saksela, Erkki HÃ¶lttÃ¤

Published Feb 23, 2016 · Vol. 7, No. 12 · pp. 15065-15092

Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment Research Paper

Haa-Na Song, Chung Lee, Seung Tae Kim, Sun Young Kim, Nayoung K.D. Kim, Jiryeon Jang, Mihyun Kang, Hyojin Jang, Soomin Ahn, Seok Hyeong Kim, Yoona Park, Yong Beom Cho, Jeong Wook Heo, Woo Yong Lee, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Young Suk Park, Woong-Yang Park, Jeeyun Lee, Hee Cheol Kim

Published Feb 20, 2016 · Vol. 7, No. 15 · pp. 19610-19619

Validation of a preclinical model for assessment of drug efficacy in melanoma Research Paper

Julie Delyon, Mariana Varna, Jean-Paul Feugeas, AurÃ©lie Sadoux, Saliha Yahiaoui, Marie-Pierre Podgorniak, Geoffroy Leclert, Sarra Mazouz Dorval, Nicolas Dumaz, Anne Janin, Samia Mourah, CÃ©leste LebbÃ©

Published Feb 20, 2016 · Vol. 7, No. 11 · pp. 13069-13081

Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions Clinical Research Papers

Chenghao Yi, Yanqing Huang, Xing Yu, Xiaofen Li, Shu Zheng, Kefeng Ding, Jinghong Xu

Published Feb 19, 2016 · Vol. 7, No. 13 · pp. 17265-17274

Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway Research Paper

Jung Ho Kim, Jeong Mo Bae, Nam-Yun Cho, Gyeong Hoon Kang

Published Feb 13, 2016 · Vol. 7, No. 12 · pp. 14095-14111

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo Research Paper

Michael Y. Bonner, Isabella Karlsson, Monica Rodolfo, Rebecca S. Arnold, Elisabetta Vergani, Jack L. Arbiser

Published Feb 9, 2016 · Vol. 7, No. 11 · pp. 12857-12868

The status of epidermal growth factor receptor in borderline ovarian tumours Research Paper

Rania Showeil, Claudia Romano, Mikel Valganon, Maryou Lambros, Pritesh Trivedi, Susan Van Noorden, Ruethairat Sriraksa, Dalal El-Kaffash, Nour El-Etreby, Rachael Natrajan, Letizia Foroni, Richard Osborne, Mona El-Bahrawy

Published Feb 8, 2016 · Vol. 7, No. 9 · pp. 10568-10577

The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway Research Paper

Hiroyoshi Kurihara, Reo Maruyama, Kazuya Ishiguro, Shinichi Kanno, Itaru Yamamoto, Keisuke Ishigami, Kei Mitsuhashi, Hisayoshi Igarashi, Miki Ito, Tokuma Tanuma, Yasutaka Sukawa, Kenji Okita, Tadashi Hasegawa, Kohzoh Imai, Hiroyuki Yamamoto, Yasuhisa Shinomura, Katsuhiko Nosho

Published Feb 8, 2016 · Vol. 7, No. 11 · pp. 12704-12717

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Research Paper

Shang-Gin Wu, Yi-Nan Liu, Meng-Feng Tsai, Yih-Leong Chang, Chong-Jen Yu, Pan-Chyr Yang, James Chih-Hsin Yang, Yueh-Feng Wen, Jin-Yuan Shih

Published Feb 4, 2016 · Vol. 7, No. 11 · pp. 12404-12413

The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response Research Paper

Rosamaria Pinto, Simona De Summa, Sabino Strippoli, Brunella Pilato, Amalia Azzariti, Gabriella Guida, Michele Guida, Stefania Tommasi

Published Feb 3, 2016 · Vol. 7, No. 18 · pp. 25135-25149

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M^high melanoma cell populations Research Paper

Mariusz L. Hartman, Beata Talar, Malgorzata Sztiller-Sikorska, Dariusz Nejc, Malgorzata Czyz

Published Jan 27, 2016 · Vol. 7, No. 8 · pp. 9026-9040

Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites Research Paper

Byungho Lim, Chan Kim, Jeong-Hwan Kim, Woo Sun Kwon, Won Seok Lee, Jeong Min Kim, Jun Yong Park, Hyo Song Kim, Kyu Hyun Park, Tae Soo Kim, Jong-Lyul Park, Hyun Cheol Chung, Sun Young Rha, Seon-Young Kim

Published Jan 22, 2016 · Vol. 7, No. 7 · pp. 8055-8066

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients Research Paper

Suppression of B-Raf(V600E) cancers by MAPK hyper-activation Research Paper

High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor Research Paper

Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer Research Paper

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients Research Paper

Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy Research Paper

Mitochondrial oxidative phosphorylation controls cancer cellâ€™s life and death decisions upon exposure to MAPK inhibitors Research Paper

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors Research Paper

Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression Research Paper

Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment Research Paper

Validation of a preclinical model for assessment of drug efficacy in melanoma Research Paper

Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions Clinical Research Papers

Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway Research Paper

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo Research Paper

The status of epidermal growth factor receptor in borderline ovarian tumours Research Paper

The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway Research Paper

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Research Paper

The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response Research Paper

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M^high melanoma cell populations Research Paper

Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients Research Paper

Suppression of B-Raf(V600E) cancers by MAPK hyper-activation Research Paper

High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor Research Paper

Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer Research Paper

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients Research Paper

Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy Research Paper

Mitochondrial oxidative phosphorylation controls cancer cellâ€™s life and death decisions upon exposure to MAPK inhibitors Research Paper

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors Research Paper

Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression Research Paper

Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment Research Paper

Validation of a preclinical model for assessment of drug efficacy in melanoma Research Paper

Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions Clinical Research Papers

Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway Research Paper

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo Research Paper

The status of epidermal growth factor receptor in borderline ovarian tumours Research Paper

The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway Research Paper

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Research Paper

The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response Research Paper

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-Mhigh melanoma cell populations Research Paper

Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites Research Paper

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M^high melanoma cell populations Research Paper